As the Gαq signalling mutations form the most clonal and most common genetic alteration in the primary tumour, they represent a relatively generic marker of the malignant cells and can be used to quantify the abundance of melanoma-cell derived DNA [20]. The gene discussed is GNAQ; the disease is neoplasm.